Source: Annual Congress 2008 - New treatments for asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. P. Boulet, C. Lemiere, G. Gauvreau, R. Olivenstein, D. Lougheed, B. Paradis, P. O‘Byrne, R. Pageau, P. Renzi (Ste-Foy/QC, Montreal/QC, Hamilton, ON, Montreal, QC, Kingston, ON, Laval, QC, Canada). Safety, efficacy and pharmacokinetics of inhaled TPI 1020 in smokers with asthma. Eur Respir J 2008; 32: Suppl. 52, 3016

Member's Comments

No comment yet.

Related content which might interest you: Efficacy of low dose theophylline and inhaled corticosteroids in smokers with asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Efficacy and safety of budesonide/formoterol comparing with budesonide and theophylline in Japanese adult patients with asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Efficacy and safety of AZD3199, an inhaled ultra long-acting β2-agonist, in patients with COPD Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011 Safety of inhaled corticosteroids reduction in asthmatic children Source: Eur Respir J 2006; 28: Suppl. 50, 712s Year: 2006 Long-term safety of inhaled formoterol in adult asthma patients Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 Efficacy of inhaled ciclesonide compared with oral prednisolone in the treatment of asthma exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 206s Year: 2006 Safety of formoterol reliever therapy compared with terbutaline in asthmatic children taking anti-inflammatory therapy Source: Eur Respir J 2002; 20: Suppl. 38, 431s Year: 2002 24-h efficacy and pharmacokinetics of tiotropium Respimat® 5 μg in patients with asthma Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Efficacy and tolerability of formoterol Turbuhaler in 6–11 year old children with asthma, not adequately controlled with inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 430s Year: 2002 Efficacy and safety of transdermal tulobuterol (LABA) on asthma patients Source: Annual Congress 2007 - New treatments for asthma Year: 2007 Efficacy and safety of high-dose inhaled corticosteroids therapy in children with asthma Source: Annual Congress 2010 - Allergy and risk factors in paediatrics Year: 2010 Safety and tolerability of high-dose formoterol via aerolizer and salbutamol via MDI in patients with mild-to-moderate COPD Source: Eur Respir J 2003; 22: Suppl. 45, 285s Year: 2003 Impact of spacer use on the efficacy and safety of ciclesonide MDI in children with persistent asthma Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Safety and efficacy of formoterol delivered via a novel DPI device in children with asthma Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management Year: 2010 Cardiac safety of indacaterol, a novel once-daily bronchodilator, in asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Efficacy of indacaterol in COPD is maintained irrespective of inhaled corticosteroid (ICS) use Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011 Safety of once-daily QMF149 in patients with persistent asthma Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Low systemic exposure of NVA237, an inhaled once-daily anticholinergic bronchodilator, in healthy humans Source: Eur Respir J 2006; 28: Suppl. 50, 661s Year: 2006 Efficacy and safety of therapeutic and supratherapeutic doses of indacaterol compared to salmeterol and salbutamol, in mild-to-moderate asthma Source: Eur Respir J 2006; 28: Suppl. 50, 207s Year: 2006 Prescribed doses and effect on asthma treatment outcomes of extrafine (ciclesonide) vs standard particle inhaled corticosteroids (ICS) Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015